RecruitingNot ApplicableNCT06286644

Hop Compounds on the Immune System (VH)

Effect of Iso-alpha Acids and Xanthohumol on the Human Immune System


Sponsor

University of Vienna

Enrollment

14 participants

Start Date

May 30, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the present study is to determine the effect of Iso-alpha-Acids and Xanthohumol from hops on the immune response of healthy participants over a timeframe of 6 hours.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Iso-alpha-Acids, Xanthohumol, and others for people with inflammatory response. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTXanthohumol

Participants receive a study drink supplemented with Xanthohumol (0 mg = Placebo, 0,125 mg, 0,375 mg or 0,75 mg soluble Xanthohumol)

DIETARY_SUPPLEMENTIso-alpha-Acids

Participants receive a study drink supplemented with Iso-alpha-Acids (0 mg = Placebo, 15 mg, 45 mg or 90 mg Iso-alpha-Acids)

DIETARY_SUPPLEMENTXanthohumol + Iso-alpha-Acids

Participants receive a study drink supplemented with Xanthohumol + Iso-alpha-Acids (0 mg = Placebo, 0,125 mg + 15 mg , 0,375 mg + 45 mg or 0,75 mg + 90 mg soluble Xanthohumol + Iso-alpha-Acids)


Locations(1)

University of Vienna

Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06286644


Related Trials